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Abstract
Background: The ability of pathogens to adapt to the widely used biocide, triclosan, varies substantially. The
purpose of the study was to examine bacterial adaptation over an extended period of time to low increments of
triclosan concentrations. Focus was two human pathogens, S. aureus and L. monocytogenes that previously have
displayed inherent high and low adaptability, respectively.
Results: Three strains of L. monocytogenes and two strains of S. aureus including the community-acquired USA300
were exposed to increasing, sub-lethal concentrations of triclosan in triclosan-containing agar gradients. Following
25 days of exposure on agar plates to sub-lethal concentrations of triclosan with a twofold concentration increase
every second day, minimum inhibitory concentration (MIC) for S. aureus increased from 0.125 (8325–4) and 0.0625
(USA 300) mg/L to 4 mg/L. The MIC of all three L. monocytogenes strains was initially 4 mg/L and remained
unaltered by the exposure. The adapted S. aureus isolates retained normal colony size but displayed increased
expression of fabI encoding an essential enzyme in bacterial fatty acid synthesis. Also, they displayed decreased or
no expression of the virulence associated agrC of the agr quorum sensing system. While most adapted strains of
USA300 carried mutations in fabI, none of the adapted strains of 8325–4 did.
Conclusions: Adaptability to triclosan varies substantially between Gram positive human pathogens. S. aureus
displayed an intrinsically lower MIC for triclosan compared to L. monocytogenes but was easily adapted leading to
the same MIC as L. monocytogenes. Even though all adapted S. aureus strains over-expressed fabI and eliminated
expression of the agr quorum sensing system, adaptation in USA300 involved fabI mutations whereas this was not
the case for 8325–4. Thus, adaptation to triclosan by S. aureus appears to involve multiple genetic pathways.
Keywords: Staphylocooccus aureus, Listeria monocytogenes, Adaptation, Triclosan
Background
Biocides are used extensively in our society for cleaning
and disinfection purposes. Triclosan is a bisphenol bio-
cide and has been widely used for the past 30 years, for
a broad range of applications. Triclosan is used in many
household products such as soaps, shampoos, deter-
gents, tooth paste and it is also used to prevent or
reduce bacterial contamination in many cosmetics [1,2].
These products typically contain concentrations of tri-
closan ranging from 0.1 to 0.3% by weight, correspond-
ing to 1000 to 3000 mg/L [1].
In the food industry, triclosan has been incorporated
into different types of plastics including food storage
containers and chopping boards [3]. In these food asso-
ciated bacteria including pathogens such as Listeria
monocytogenes may be repeatedly exposed to the com-
pound [4]. In the hospital environment pathogens may
encounter triclosan when it is employed in surgical
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scrubs, sutures and soaps [5,6]. For patients that are
carriers of methicillin resistant Staphylococcus aureus
(MRSA), triclosan body wash has been used to eradicate
MRSA carriage prior to surgery [5,7].
The extensive use of triclosan is also reflected in its
environmental presence. Several studies have detected
triclosan in the external environment such as in streams
and rivers [8,9], surface waters downstream of wastewa-
ter treatment plants [8], biosolids [10] and accumulating
in higher organisms such as snails and fish [1,11]. Con-
centrations in the natural aquatic environment are
detected to a maxima of 0.0023 mg/L and freshwater
sediments range from 0.8 – 53 mg/kg [12]. As the con-
centration of triclosan increases in the environment, one
may fear that bacteria with decreased susceptibility to
the compound will be selected for [13,14].
In contrast to many biocides, triclosan has a specific cel-
lular target, namely the enoyl-acyl carrier protein reduc-
tase isoform, FabI, an essential enzyme in bacterial fatty
acid synthesis [15]. At low concentrations, triclosan in-
hibits fatty acid synthesis by inhibiting FabI that uses
NADH to reduce a double bond during each cycle of bac-
terial fatty acid elongation [16]. At higher concentration,
the bisphenol causes gross damage to bacterial cell mem-
branes and disrupts protein and lipid biosynthesis [17,18].
While resistance to biocides at working concentrations
is rare, increased tolerance to triclosan is commonly ob-
served for many bacterial species including S. aureus
[16,19-23]. There are multiple pathways by which bacterial
cells may become more tolerant to triclosan including
point mutations in fabI [15,24,25], overexpression of
FabI [25,26] or increased efflux pump activity extruding
the compound [27]. Interestingly, the latter activity has
been associated with quinolone resistance in E. coli,
Pseudomonas aeruginosa and S. aureus [15,28-30]. Other
phenotypic changes accompanying triclosan tolerance
have been noted. In S. aureus exposure to triclosan has
given rise to small colony variants (SCV) that in
addition to altered metabolism and virulence gene ex-
pression are resistant to gentamicin [31]. Interestingly,
short term exposure of Listeria monocytogenes to triclo-
san in sub-lethal concentrations did not result in an al-
tered MIC towards triclosan but caused cells to develop
resistance to gentamicin and other aminoglycosides
[32]. This finding suggests that an adaptation to triclo-
san occured in these bacteria even though the triclosan
MIC was not affected.
Since the literature suggests that Gram positive bac-
teria have different adaptation mechanisms to triclosan
it is important to address this question in a controlled
study using the same adaption methodology and using
small increments in triclosan concentrations over an ex-
tended period of time to mimic the repeated exposure in
e.g. hospital or food processing environments.
Methods
Bacteria and growth conditions
The following strains were used in the adaptation
studies: S. aureus 8325–4 [33] S. aureus USA300 LAC
[34], L. monocytogenes F2365 (LMG 23356) [35],
L. monocytogenes N53-1 [36] and L. monocytogenes EGD
(obtained from Werner Goebel, Biozentrum, University of
Würzburg, Germany). For the hemolysin assay S. aureus
RN4220 (26) was used. In the assesment of efflux activity,
strains JCM 16555 (qacA) and JCM 16556 (qacB) were
included as controls (both kindly provided by Japan Col-
lection of Microorganisms, RIKEN BRC which is partici-
pating in the National BioResource Project of the MEXT,
Japan). S. aureus strains were grown in Mueller Hinton
(MH) broth (Oxoid, Denmark) or Tryptic Soy broth (TSB)
(Oxoid) or on corresponding agar plates (MHA, TSA)
(Oxoid). L. monocytogenes was grown in Brain Heart Infu-
sion (BHI) broth (Oxoid) or on BHI agar plates (Oxoid).
All cultures were incubated under aerobic conditions at
37°C and broth cultures were shaken at 200 rpm. Triclosan
(Irgasan; Sigma-Aldrich) was dissolved (1000 mg/L) in
96% ethanol (Kemotyl, Denmark) for adaptation on plates
and in 70% ethanol for the adaptation in broth, and fur-
ther diluted in growth medium and added to the samples
when indicated.
Adaptation on gradient agar plates
A Triclosan-gradient was constructed in TSA (S. aureus)
or BHI-agar (L. monocytogenes) in four-sided petri
dishes. Each bacterial isolate was inoculated as streaks
on these plates (7 replicas per strain) and the plates in-
cubated 1 day at 37°C. After incubation, the colony mass
was swabbed from 1 cm at the leading edge of growth
(at the highest triclosan concentration) and re-streaked
on agar plates with the same triclosan gradient. If there
was bacterial growth on the entire inoculation streak the
bacteria were streaked on agar plates were the triclosan
concentration in the bottom layer was twice as high. If
no growth was observed the bacteria were streaked again
on agar plates with the same triclosan gradient. The ini-
tial concentration of triclosan in the bottom layer was
0.002 for S. aureus 8325–4 and all L. monocytogenes
strains, and 0.0002 μg/ml for S. aureus USA300.
For controls, the five bacterial strains were sub-
cultivated on agar plates without triclosan as often as bac-
teria grown on triclosan gradient plates. When it was no
longer possible to increase the concentration of triclosan
in the gradient plates the 7 replicas and 2 controls were
frozen at −80°C as single colonies.
After adaptation all S. aureus isolates were confirmed
as S. aureus by use of Rapid Staph Test kit (Oxoid) and
all L. monocytogenes isolates confirmed on Rapid’L.
mono plates (Bio-Rad).
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Adaptation in broth
Listeria monocytogenes EGD and N53-1 were grown se-
quentially with triclosan in BHI as described previously
[37] with minor modifications. Following five transfers
in BHI without triclosan, each of five individually pas-
saged sets of both strains were exposed to 0.05 μg/ml
triclosan and two to 0.7% ethanol as negative control.
The experiment was conducted for approx. 70 transfers
with 1:100 fold dilutions, giving a total of 420–490 bac-
terial generations. All selection lines were streaked daily
on BHI-agar to check purity and occasionally verified as
Listeria by cultivation on Listeria selective agar base
(Oxoid) supplemented with modified Listeria selective
supplement (Oxoid).
Estimation of triclosan tolerance, MIC and minimum
bacteriocidal concentration (MBC)
The MIC of triclosan was determined following the rec-
ommendations of the British Society of Antimicrobial
Chemotherapy using broth microdilutions (CLSI). A
stock solution of triclosan was prepared in advance and
a doubling dilution range from 0.0156 - 8 mg/l triclosan
in Muller-Hinton bouillon (MHB) was made for each ex-
periment. Triclosan dilution (100 μl) and 100 μl of an
over night bacterial suspension adjusted to 10^6 CFU/
ml was mixed in each well. The MIC was determined as
the lowest concentration that inhibited visible growth
after 24 hours. Bacterial growth in the highest dilution
of 96% ethanol used was also tested and did not differ
visually from growth in MHB alone. From each well
(0.0625 mg/l and above) 10 μl was, after 24 hours incu-
bation, spotted on to Muller-Hinton agar (MHA) plates
containing no triclosan. The MBC was read as the low-
est concentration with no growth after 48 hours. All
MIC determinations were made with two biological and
two technical replicates and MIC is given as the mean.
Sequencing of fabI
Genomic DNA of S. aureus was isolated using the boiling
method as described previously [38] and fabI amplified by
PCR (with a mixture of 25 μl DreamTaq™Green PCR Mas-
ter Mix ([2×]), 1 μM of each primer, 1 μl DNA template
and water to a total volume of 50 μl). Primers adapted
from those designed for the amplification of the staphylo-
coccal fabI gene and putative promoter region were used
in 50 μl PCRs (fab1F: tgttccgcatggagatacac and fab1R:
taaggactaattctgtggatgt) [39]. The PCR was performed with
an initial 5 min denaturation at 95°C, followed by 35 cycles
of denaturation at 94°C for 30 s, annealing at 50°C for 30 s
and extension at 72°C for 45 s, followed by a final ex-
tension step at 72°C for 5 min. The PCR products were
purified using 10 units Exonuclease I (ExoI) and 1 unit
FastAP™Thermosensitive Alkaline Phosphatase mixed with
5 μl PCR product, then incubated at 37°C for 15 min and
85°C for 15 min. The purified PCR products were se-
quenced at both strands using Macrogenservice.
RNA extraction and northern hybridization
Cells of S. aureus were grown to mid logarithmic growth
phase (OD600 = 0.6-0.8) in MH broth and samples were
immediately cooled in ice-water bath. The bacterial cells
were lysed using Fast Prep FP120 instrument (BIO101,
ThermoSavent) for 45 s at speed 6.0. Total RNA was
extracted from the cells using RNeasy mini kit (Qiagen,
Denmark) according to the manufacturer’s directions.
Analysis of transcripts was made as previously described
[40]. Hybridization probes were generated by PCR from
chromosomal DNA of S. aureus 8325–4 using specific
primers for the fabI gene (fab2F: atgttaaatcttgaaaacaaaac
and fab2R: ttatttaattgcgtggaatccgc) [39], the mepA gene
(mepAF: ggaaacttcgcgattgca and mepAR: gcacaaagtga
ctcagca), the norA gene (norAF: tgtttgcagttggccaca and
norAR: cgccacccgtaatagcaa) and rnaIII (rnaIIIF: gggg
atcacagagatgtgatg and rnaIIIR: gggcatagcactgagtccaagg)
(TAG Copenhagen A/S, Denmark). RNA extracted from
at least two independent experiments was analysed.
Hemolytic activity
Hemolytic activity was evaluated on sheep blood as de-
scribed previously [41].
Assessment of efflux activity
Efflux pump activity was analysed by ethidium bromide
(EtBr) assay as described previously [42]. Isolates were
grown for 24 h at 37°C on TSA containing EtBr (1 mg/L),
followed by inspection under UV light.
Deoxyribonuclease (DNAse) activity
DNAse activity was determined semi-quantitatively on
DNase agar (Oxoid). After overnight incubation, clearing
zones after addition of 1 M hydrochloric acid were mea-
sured using calipers.
Metabolic activity using XTT
(2,3-bis-[2-methoxy-4-nitro-5-sulfopheny l]-2H-tetrazolium-
5-carboxanilide) (Sigma). A colorimetric assay where the
colorless XTT is reduced to the water soluble formazan
dye by metabolically active cells was used to compare the
metabolic activity between triclosan adapted strains and
non adapted strains. Cultures were grown over night,
harvested by centrifugation (8000 rpm, 10 min) (Eppendorf
minispin (F-45-12-11) and resuspended in XTT. The XTT
suspension was incubated at 37°C, dark and with shake for
3 h. The cultures were centrifuged (8000 rpm, 10 min)
(Eppendorf minispin (F-45-12-11) and OD490 measured on
supernatant.
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Table 1 Minimum inhibitory concentration (MIC) and minimum bacteriocidal concentration (MBC) values for S. aureus
8325–4, S. aureus USA300, L. monocytogenes EGD, L. monocytogenes N53-1 and L. monocytogenes F2365
Strain MIC 24 h (mg/L) MIC 48 h (mg/L) MBC 24 h (mg/L) MBC 48 h (mg/L)
S. aureus 8325-4
Freezer stock 0.125 0.25 2 2
Passaged 1 0.125 0.25 2 2
Passaged 2 0.125 0.25 2 2
Adapted 1 2 4 8 8
Adapted 2 2 4 8 8
Adapted 3 1 2 8 8
Adapted 4 2 4 8 8
Adapted 5 2 4 8 8
Adapted 6 2 4 8 8
Adapted 7 2 2 8 8
S. aureus USA300
Freezer stock 0.0625 0.125 1 2
Passaged 1 0.125 0.25 4 4
Passaged 2 0.125 0.25 4 4
Adapted 1 2 2 8 8
Adapted 2 2 2 8 8
Adapted 3 2 4 8 8
Adapted 4 2 4 8 8
Adapted 5 2 4 8 8
Adapted 6 2 4 8 8
Adapted 7 2 4 8 8
L. monocytogenes EGD
Freezer stock 2 4 8 8
Passaged 1 2 4 8 8
Passaged 2 2 4 8 8
Adapted 1 4 4 8 8
Adapted 2 4 4 8 8
Adapted 3 4 4 8 8
Adapted 4 4 4 8 8
Adapted 5 4 4 8 8
Adapted 6 4 4 8 8
Adapted 7 4 4 8 8
L. monocytogenes N53-1
Freezer stock 2 4 8 8
Passaged 1 2 4 8 8
Passaged 2 2 4 8 8
Adapted 1 4 4 8 8
Adapted 2 4 4 8 8
Adapted 3 4 4 8 8
Adapted 4 4 4 8 8
Adapted 5 4 4 8 8
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Attachment
S. aureus strains were grown in TSB to OD600 0.05 and
100 μl pre-culture was added to a 96-well microtiter plate
(Sarstedt) and incubated overnight at 37°C. Then, each
well was washed three times with 200 μl physiological sa-
line and stained with 0.1% crystal violet for 30 min. The
crystal violet was washed out and each well washed three
times with water. The amount of attachment was deter-
mined after dissolving the crystal violet with 96% ethanol
for 30 min and read by spectrophotometer at 490 nm.
Antimicrobial susceptibility
MICs of gentamicin and vancomycin were measured
using Etest (bioMerieux-Diagnostics, Denmark).
Results and discussion
S. aureus but not L. monocytogenes adapts to triclosan
To compare the adaptability of L. monocytogenes and
S. aureus to triclosan, both species were exposed to daily
sub-cultivations on agar plates without or with gradient
concentrations of triclosan (see Methods). For S. aureus
also parallel passage of 7 single colonies of each of the two
strains USA300 and 8325–4 were made. S. aureus 8325–4
is a common laboratory strain while USA300 is a commu-
nity associated MRSA that is causing serious infections in
the USA and many other countries [43]. After 25 days of
daily passages the highest concentration of triclosan in the
top agar layer that supported growth of S. aureus was
4 mg/L triclosan for both 8325–4 and for USA300. Colony
material from each of the 7 exposed cultures and 2
controls (eg. sub-cultivated without triclosan) was stored
for further characterization. The MIC and MBC were
determined for the isolates. Interestingly, both strains of
S. aureus increased their MIC about 16 fold and also the
MBC was substantially increased compared to the frozen
stock and strains passaged without triclosan (Table 1). The
adapted strains were subsequently passaged in the absence
of triclosan and the MIC of the adapted cells remained un-
altered indicating that genetic changes were responsible
for the altered MIC (data not shown).
When L. monocytogenes strains EGD, F2365 (LMG23356)
and N53-1 were passaged similarly, the highest concentra-
tion of triclosan in the top agar layer supporting growth
was 1.28 mg/L for N53-1 and EGD whereas F2365 was able
to grow in the presence of 4 mg/L triclosan in the top layer.
L. monocytogenes EGD is a laboratory strain whereas N53-1
was isolated from fish processing industry and F2365
(LMG23356) is from a Mexican-style soft cheese [35,36].
The adapted isolates of L. monocytogenes F2365 and EGD
multiplied only at slightly higher triclosan concentration
than the controls (freeze stock and strains passaged with no
triclosan) (Table 1). In order to address if adaptation of
L. monocytogenes may occur during growth in liquid broth
L. monocytogenes EGD and N53-1 were passaged with in-
creasing concentrations of triclosan. However, after ten
transfers in 4.8 mg/L, none of the ten selection lines were
able to grow in 6.4 mg/L (data not shown). Again it was
found that the MIC of the exposed strains was similar to
the triclosan unexposed bacteria (data not shown). Thus,
the inherent tolerance of two Gram positive bacterial
species towards triclosan differed substantially with
L. monocytogenes being 16 fold more tolerant than
S. aureus. In contrast, S. aureus readily adapts to triclosan
and the final MIC of the adapted S. aureus cells approx-
imates that of the unadapted L. monocytogenes.
Efflux pump activity is not altered in triclosan adapted
S. aureus strains
With the aim of determining if the adaptation processes
are the same in the two strains of S. aureus, namely the
Table 1 Minimum inhibitory concentration (MIC) and minimum bacteriocidal concentration (MBC) values for S. aureus
8325–4, S. aureus USA300, L. monocytogenes EGD, L. monocytogenes N53-1 and L. monocytogenes F2365 (Continued)
Adapted 6 4 4 8 8
Adapted 7 4 4 8 8
L. monocytogenes F2365
Freezer stock 2 4 8 8
Passaged 1 2 4 8 8
Passaged 2 2 4 8 8
Adapted 1 4 4 8 8
Adapted 2 4 4 8 8
Adapted 3 4 4 8 8
Adapted 4 4 4 8 8
Adapted 5 4 4 8 8
Adapted 6 4 4 8 8
Adapted 7 4 4 8 8
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laboratory strain 8325–4 and the clinical isolate
USA300, the adapted isolates were characterized. Previ-
ously, enhanced expression of the AcrAB efflux pump
has been associated with increased tolerance to triclosan
in E. coli [27]. To address if efflux pump activity may be
part of the adaptation process in S. aureus strains, the
efflux activity was examined by monitoring extrusion of
ethidium bromide [44]. As shown in Figure 1 noobvious
differences in ethidium bromide staining of triclosan tol-
erant and adapted strains were observed indicating that
they are equally able to extrude the compound. Tran-
scription of norA and mepA were also measured and no
differences between triclosan adapted strains and their
controls were observed (data not shown).
fabI sequence and expression
Increased tolerance to triclosan may be a consequence
of mutations in fabI encoding the enoyl-ACP reductase
that is essential for S. aureus fatty acid biosynthesis [25].
To address if the gene was mutated in the adapted
S. aureus strains, the fabI of both triclosan adapted and
unadapted cells of S. aureus 8325–4 and USA300 was
sequenced. For the triclosan adapted isolates of strain
8325–4 no mutations were found in the 1358 bp DNA
region covering the fabI gene and promoter region when
compared to the sequence of the freezer stock of 8425–
4 and the passaged control cells. In contrast, several mu-
tations occurred in the fabI gene and promoter region of
the adapted USA300 isolates compared to the passaged
but un-exposed control cells and the published sequence
of USA300 (Table 2). fabI mutations previously associ-
ated with triclosan tolerance are a substitution of a
phenylalanine for a cysteine or serine at position 204
(F204C) (F204S) [25,45], a glycine for a serine at position
23 (G23S) [16] or an aspartic acid for a threonine in pos-
ition 101 [45]. The F204C mutation does not allow tri-
closan to form a stable complex between NAD + and
FabI-triclosan contributing to the decrease in sensitivity
[25]. Mutations in position 204 in four of the seven tri-
closan adapted USA300 isolates were also identified
here. Two isolates had the previously identified F204C
substitution but in addition substitutions in F204L and
F204S were also found (Table 2). Further a substitution
in A24T was identified in one isolate, D101Y in another
isolate and I193F in again two other isolates. No amino
acid changes were observed in any of the isolates pas-
saged without triclosan. It is clear from this and previous
studies [25,45] that a mutation in position 204 is import-
ant for S. aureus in adaptation to triclosan. However, the
mutation does not seem to be essential as other muta-
tions were also discovered and even strains with no mu-
tations in fabI were adapted to triclosan. Analysis of
recognition, interaction and binding of triclosan to
S. aureus FabI showed that F204 is one of the interacting
residues located within the substrate-binding loop of FabI
[46]. This could be an explanation for the frequently iden-
tified mutations in this position that probably prevent op-
timal binding and activity of triclosan to FabI.
Increased expression of the wild type FabI has also
been related to enhanced tolerance to triclosan in S. aureus
Table 2 Aminoacid substitutions in FabI of USA300 strains passaged either in the absence (C1 and C2) or presence
(A1 through A7) of triclosan compared to the genome sequence (34)
Aminoacid number (from gene start) C1 C2 A1 A2 A3 A4 A5 A6 A7
Upstream of fabI
−74 M→ R
−32 I→ T
−19 V→D
fabI
24 A→ T
101 D→ Y
193 I→ F I→ F
204 F→ L F→ S F→ C F→ C
Minus positions are upstream of the protein start. Abbreviations for amino acids are: M Methionine, R Arginine, I Isoleucine, T Threonine, V Valine, D aspartic acid,
A alanine, N asparagine, F Phenyl alanine, C cysteine, L Leucine, S Serine.
8325-4 USA300
JCM  16555 JCM1656 C1 C2
Wt A1 A2 A3 Wt A1 At  A3
A4 A5  A6  A7 A4 A5  A6  A7
JCM 16555 JCM1656 C1 C2
Figure 1 EtBr efflux activity in triclosan exposed S. aureus cells.
Isolates were grown for 24 h at 37°C on TSA containing EtBr
(1 μg/ml), followed by inspection for fluorescence under UV light as
described previously. Wt (freeze stock), C1 and C2 (two controls
passed on TSA without triclosan), A1-A7 (7 triclosan adapted strains).
Strains JCM 16555 (qacA) and JCM 16556 (qacB) (lower left), that
overexpress efflux pumps, were included as controls.
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[39] although to a lesser degree than mutations in the fabI
gene [25]. To examine if altered expression of fabI is re-
lated to triclosan adaptation particularly in strain 8325–4,
where no fabI mutations were detected, the amounts of
fabI mRNA produced during growth in MH medium were
compared (Figure 2). In all the adapted isolates of strains
8325–4, fabI was strongly overexpressed indicating that
this may contribute to the decreased triclosan susceptibil-
ity. Also, in most of the adapted isolates of strain USA300
increased fabI expression was seen. This indicates that in
these strains both mutations in and expression of fabI may
influence triclosan susceptibility. Interestingly, it was also
observed that in the un-adapted strains, fabI was expressed
as a monocistronic transcript but in several of the adapted
strains larger transcripts appeared. The fabI gene is located
94 bp downstream of an open reading frame (designated
USA300HOU_0968) oriented in the same direction as fabI.
Sequencing of USA300HOU_0968 and intergenic region
in the adapted isolates of USA300 revealed various muta-
tions but none of them appeared in more than one isolate
(Table 2). However, it is predicted that USA300HOU_0968
and fabI form an operon and that mutations in
USA300HOU_0968 and fabI enhance expression of
the operon.
Virulence factor expression is altered in triclosan adapted
strains
Previous studies have indicated that exposure of S. aureus
to triclosan may lead to a SCV phenotype characterized
by slow growth and pin point small colonies [31,47]. The
common underlying factor in induction of the SCV
phenotype is reduced bacterial energy generation/
transport leading to reduced cell wall synthesis and
virulence factor production including hemolysis, co-
agulase and DNAse. Importantly, both the adapted
strain 8325–4 and USA300 formed colonies of regular
size when compared to unexposed cells (data not
shown). In order to further confirm that respiration in
Figure 3 Hemolytic activity of S. aureus on sheep blood.
RN4220, a strong beta-hemolysin producer, is streaked vertically, and
at right wt (freeze stock), C1 and C2 (two controls passed on TSA
without triclosan). At right from top and down A1-A7 (7 triclosan
adapted strains). Beta-hemolysin forms a tubid zone of hemolysis
surrounding the vertical streak of RN4220. Delta-hemolysis and beta-
hemolysis are synergistic, producing a clear hemolysis where
they intersect.
S. aureus USA300 Wt  C1 C2 A1 A2 A3 A4 A5 A6 A7
S. aureus 8325-4  Wt  C1 C2 A1 A2 A3 A4 A5 A6 A7
Figure 4 RNAIII expression in triclosan exposed S. aureus cells.
Northern blot displaying rnaIII expression from USA300 and 8325-4.
Starting from left: wt (freeze stock), C1 and C2 (two controls passed
on TSA without triclosan), A1-A7 (7 triclosan adapted strains).
Wt  C1 C2  A1 A2 A3 A4 A5  A6 A7
USA300
8325-4
A
B
Figure 2 fabI expression in triclosan exposed S. aureus cells.
Northern blot showing fabI expression with A. USA300 and B. 8325-4.
From left: wt (freeze stock), C1 and C2 (two controls passed on TSA
without triclosan), A1-A7 (7 triclosan adapted strains).
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the adapted strains was comparable to wild type cells,
enzymatic activity using XTT assay was monitored and
no differences were found between adapted, passaged
and control strains (freeze stocks) (data not shown). In
contrast to previous studies, it was not found that tri-
closan exposure lead to SCV. One explanation may be
that this study used TSA growth medium compared to
the less nutritious MHA used in other studies [31,47].
Thus, S. aureus adapts to triclosan and interestingly
different strains use different measures to decrease
susceptibility.
Although no SCVs were observed in response to tri-
closan in this study the effect of adaptation on virulence
gene expression was examined [48]. One of the key viru-
lence factors in S. aureus is α-hemolysin encoded by hla.
Hemolysin activity is conveniently evaluated on sheep
blood agar plates and results showed that all but one
(8325–4 A7) of the adapted strains of S. aureus USA 300
and 8325–4 displayed little or no hemolytic activity in
contrast to the freezer stocks of the strains. Curiously,
the isolates that had been passaged in the absence of tri-
closan also expressed less hemolytic activity compared
to the original stock but greater activity than the triclo-
san adapted isolates (Figure 3). hla is regulated by the ef-
fector molecule RNAIII and where hla is decreased a
reduction in RNAIII level is also expected. The level of
RNAIII expression was therefore examined by Northern
blot analysis and was found to be almost abolished in
the adapted strains compared to passaged and wild type
stock strains (Figure 4). Only one adapted strain (8325–
4 A7) showed RNAIII expression correlating well with
the hemolysis observed for the same strain (Figure 3). In
addition to the toxins, S. aureus produces an array of
degradation enzymes including nucleases. Using a semi-
quantitative agar-based assay DNAse activity was moni-
tored but no differences between the adapted isolates
and the controls (passaged and wt strains) were ob-
served (data not shown). This contrasts a recent study
where triclosan exposure resulted in SCVs expressing re-
duced DNase activity [49]. In agreement with previous
findings, a significant reduction in attachment to plastic
surfaces was observed for the adapted strains of both
S. aureus 8325–4 and USA300 compared to the control
strains (data not shown) [49].
Antibiotic resistance
Sub-lethal exposure of triclosan has been shown to de-
crease susceptibility to gentamicin and other amino-
glycosides in L. monocytogenes [32]. It was examined if
that also was the case for S. aureus strains passaged in
the presence of triclosan. Here, no alterations were ob-
served for (gentamicin (0.5 μg/ml for non-adapted and
adapted S. aureus 8325–3 and 1 μg/ml for non-adapted
and adapted S. aureus USA300 strains) and the
glycopeptide antibiotic vancomycin (2 μg/ml for S. aureus
8325–4 and S. aureus USA300 with no differences be-
tween non-adapted and adapted)). These findings agree
with an earlier study where a triclosan tolerant S. aureus
was examined for its susceptibility to a number of antibi-
otics belonging to different classes but with no changes
compared to the triclosan sensitive strain [50].
Conclusion
In conclusion, this study shows that S. aureus has
intrinsically lower MIC to triclosan as compared to
L. monocytogenes but can be adapted to the same toler-
ance level. The adaptation in S. aureus is not accompanied
by antibiotic resistance but rather reduced expression of
the central virulence regulatory RNA, RNAIII and in most
cases overexpression of fabI encoding the enoyl-acyl car-
rier protein reductase isoform, the target of triclosan.
However, the phenotypic diversity of triclosan adapted
S. aureus strains suggests that multiple adaptation path-
ways may lead to decreased triclosan susceptibility. This
notion was confirmed by sequencing of the fabI gene and
promoter region revealing that while most adapted strains
of USA300 carried mutations in this region none of the
8325–4 strains did. Thus, multiple mutational events may
adapt S. aureus to triclosan and the genetic path selected
in adaptation may be strain specific.
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